Cite
HARVARD Citation
Liao, Y. et al. (2023). Bortezomib inhibits hepatocellular carcinoma via the Hippo‐Yes‐associated protein signalling pathway. Basic & clinical pharmacology & toxicology. 132 (4), pp. 297-311. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liao, Y. et al. (2023). Bortezomib inhibits hepatocellular carcinoma via the Hippo‐Yes‐associated protein signalling pathway. Basic & clinical pharmacology & toxicology. 132 (4), pp. 297-311. [Online].